Click here

Thursday 23 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Get RSS news feed

Latest News

sounding chest

Once-daily COPD portfolio
Tuesday 21st May 2013
New data from the Novartis chronic obstructive pulmonary disease (COPD) portfolio has been presented at the American Thoracic Society (ATS)...

asthma patient

Tiotropium in symptomatic asthma patients
Tuesday 21st May 2013
Tiotropium delivered by the Respimat Soft Mist Inhaler increases time to first severe exacerbation (p=0.03) and first episode of asthma worsening...

liver

Phase III trial of regorafenib in patients with advanced liver cancer
Tuesday 21st May 2013
Bayer HealthCare has announced that the company has started to enrol patients in an international Phase III trial to evaluate the efficacy and safety...

Other News

Page:

1

Voluntary Harmonisation Procedure
Tuesday 21st May 2013
Getting new innovative medicines to patients more quickly has become a step change easier thanks to...

Molecular trigger for Alzheimer’s disease
Tuesday 21st May 2013
For the first time, scientists at Cambridge’s Department of Chemistry have been able to map in...

Phase III results for afatinib and ninedanib
Tuesday 21st May 2013
Boehringer Ingelheim has announced the upcoming presentation of data from 14 abstracts involving...

Vortioxetine clinical phase III data in depression
Monday 20th May 2013
H Lundbeck A/S (Lundbeck) and partner Takeda Pharmaceutical Company Limited (Takeda) have announced...

Trust leads £260 million patient safety drive
Monday 20th May 2013
UHB is being held up as a leading example as the Government today announces a £260 million...

Sepsis code
Monday 20th May 2013
Hospital Marina Salud de Dénia has presented its Sepsis Code at the National Health IT Conference...

Merck Serono: non-small cell lung cancer Phase III trial
Friday 17th May 2013
Merck Serono, a division of Merck, Darmstadt, Germany, today announced detailed results from the...

Oncology portfolio
Friday 17th May 2013
Bayer HealthCare has announced that new data on the oncology portfolio, including Nexavar®...

US FDA approval for cancer treatment Xofigo
Friday 17th May 2013
Bayer HealthCare has announced that the US Food and Drug Administration (FDA) approved Xofigo®...

Role of nitric oxide (NO) in the physiology of the eye
Wednesday 15th May 2013
Nicox presented two scientific posters at the Association for Research in Vision and Ophthalmology...

Specialist qualification mobility
Wednesday 15th May 2013
Organisations representing professionals with specialised qualifications in the fields of...

HPE Pocket Guides
Wednesday 15th May 2013
Hospital Pharmacy Europe is delighted to announce publication of the first in a series of...

The European Cancer Organisation
Wednesday 15th May 2013
At ECCO - the European Cancer Organisation, we take our objective to create an environment in which...

Ilaris® approved by FDA
Monday 13th May 2013
Novartis announced today that the US Food and Drug Administration (FDA) has approved Ilaris®...

Accord Healthcare case successfully resolved
Monday 13th May 2013
Accord Healthcare Ltd. has successfully resolved the case against AstraZeneca relating to the...

Real-world data highlight transformational outcomes seen...
Wednesday 8th May 2013
Novartis has reported that new data with the eye drug Lucentis® (ranibizumab), first licensed in...

Bayer HealthCare joins forces with Stroke Alliance for...
Wednesday 8th May 2013
Ahead of the 'Move for Health Day' (10 May) and the 'European Stroke Day' (14 May), the Stroke...

Selincro launched in the UK
Wednesday 8th May 2013
Biotie has announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the UK....

Treatment of migraine and cluster headaches
Wednesday 8th May 2013
In a poster presented at the CONy[1] meeting in Istanbul, by Dr. Alan Rapoport of the David Geffen...

EU proposals on medical device regulation do not go far...
Wednesday 8th May 2013
As the EU debates new legislation to regulate medical devices, experts in this week's BMJ argue...

Get RSS news feed

Page:

1

Web design, hosting and programming by ModeZero